乌比奎丁蛋白质酶体功能障碍在人类的高缩性和扩张性心肌病症中
Jaime M Predmore1, Ping Wang, Frank Davis
11150 W Medical Center Dr, 7301 MSRB III, Ann Arbor, MI 48109-0644, USA.
Circulation
|February 18, 2010
概括
无处不在的蛋白质酶体系统.
科学领域:
- 心血管生物学 心血管生物学
- 分子医学是分子医学.
- 细胞生物学 细胞生物学
背景情况:
- 无素蛋白酶体系统 (UPS) 对蛋白质平衡至关重要.
- 它在人类心脏功能障碍中的作用尚不清楚.
- 这项研究调查了心力衰竭和多变性心肌病 (HCM) 中的UPS功能.
研究的目的:
- 评估在人类心力衰竭和缩性心肌病 (HCM) 中的乌比奎丁蛋白酶体系统功能.
主要方法:
- 蛋白质酶的功能被评估在人类非衰竭供体心脏,心脏衰竭,和HCM肌切除样本.
- 测量了UPS子单位的蛋白质分解活性和蛋白质含量.
- 检查了蛋白质氧化水平.
主要成果:
- 蛋白质酶蛋白质分解活性在衰竭和HCM心脏中显著降低.
- 在机械卸载后,失败的心脏的活动被部分恢复.
- 氧化修饰在心脏衰竭中增加,而蛋白质酶子单元含量没有变化.
结论:
- 在人类心肌病中,蛋白质酶的活性受损.
- 缺陷的蛋白质降解可能是由于翻译后的修改,而不是改变的蛋白质酶体含量.
- 这突出了心脏病中蛋白质积累的潜在机制.
相关概念视频
Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...


